Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pleiotropy01:33

Pleiotropy

40.6K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.6K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

596
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
596
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

1.4K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K
Dysrhythmias II: Classification of Tachyarrhythmias01:28

Dysrhythmias II: Classification of Tachyarrhythmias

11
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
11
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

438
In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
438
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

15
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
15

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Annals On Call - Alzheimer Disease: A Diagnostic Challenge.

Annals of internal medicine·2026
Same author

The Certain Uncertainty of an Alzheimer Disease Diagnosis.

Annals of internal medicine·2026
Same author

The Pattern of Adverse Drug Reaction Reporting at a Regional Pharmacovigilance Center in North India: A Retrospective Observational Study.

Cureus·2025
Same author

Comparative Effectiveness of Pitavastatin Versus Atorvastatin on Lipid Profile and Blood Sugar in Patients of Diabetic Dyslipidemia: An Open-Label Comparative Study.

Cureus·2025
Same author

Reducing ARIA risk in Alzheimer's disease: Real-world impact of <i>APOE</i> genotype-guided slow titration with aducanumab and lecanemab.

Journal of Alzheimer's disease : JAD·2025
Same author

Estrogen, menopause, and Alzheimer's disease: understanding the link to cognitive decline in women.

Frontiers in molecular biosciences·2025

相关实验视频

Updated: Jul 18, 2025

Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases
10:38

Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases

Published on: December 22, 2023

546

这些是病症.

Gayatri Devi1

  • 1Department of Neurology and Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, United States.

Handbook of clinical neurology
|August 24, 2023
PubMed
概括

病是一种神经退行性疾病,由异常的蛋白聚合物引起. 由于症状重叠和缺乏生物标志物,诊断具有挑战性,目前的治疗只能控制症状.

科学领域:

  • 神经科学是一个神经科学.
  • 神经病理学神经病理学
  • 遗传学 遗传学是一种遗传学.

背景情况:

  • 病是一种多样化的神经退行性疾病群,其特征是异常的蛋白聚合物.
  • 陶蛋白对微管稳定性和细胞内运输至关重要;其异常修饰导致神经退行.
  • 这些疾病可以是初级的 (例如,皮克病,渐进的超核性麻) 或是二级的,如阿尔茨海默氏症,其中粉样β也起作用.

研究的目的:

  • 审查病的异质性,包括它们的分类,临床表现,诊断挑战和治疗策略.
  • 突出病的复杂性,包括初级,二级和环境形式.
  • 讨论目前对病的诊断和治疗开发的局限性.

主要方法:

  • 审查有关病的现有文献,涵盖神经病理学,临床特征和治疗方法.
  • 根据tau异型,占主导地位的细胞类型和病因因素对病的分类.
  • 对诊断挑战和当前治疗环境的分析,包括疾病修饰疗法试验.

主要成果:

  • 陶病症表现出显著的临床和神经病理异质性,分为初级,二级和环境类别.
  • 临床表现有很大差异,通常涉及认知和运动症状的组合,使得诊断很难没有生物标志物.
  • 目前的治疗方法在很大程度上是症状性的,疾病修饰疗法,特别是针对阿尔茨海默病的粉样β和蛋白的治疗方法,表现出有限的成功.
关键词:
皮层骨干退行症 皮层骨干退行症病理学诊断 病理学诊断 病理学诊断选择 挑选 挑选 挑选陶氏疗法审查 陶氏疗法审查治疗阿尔茨海默氏症的治疗方法

更多相关视频

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.4K
A Reproducible Cartilage Impact Model to Generate Post-Traumatic Osteoarthritis in the Rabbit
08:42

A Reproducible Cartilage Impact Model to Generate Post-Traumatic Osteoarthritis in the Rabbit

Published on: November 21, 2023

1.2K

相关实验视频

Last Updated: Jul 18, 2025

Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases
10:38

Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases

Published on: December 22, 2023

546
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.4K
A Reproducible Cartilage Impact Model to Generate Post-Traumatic Osteoarthritis in the Rabbit
08:42

A Reproducible Cartilage Impact Model to Generate Post-Traumatic Osteoarthritis in the Rabbit

Published on: November 21, 2023

1.2K

结论:

  • 由于症状重叠和共同病理,准确的临床诊断是具有挑战性的,需要改进的诊断工具.
  • 尽管进行了广泛的研究,但对病的有效疾病修饰疗法仍然难以捉摸,这凸显了对新型治疗策略的需求.
  • 了解病症背后的多样化机制对于开发有针对性的治疗方法和改善患者的治疗结果至关重要.